Clinical Trials Browser

Phase 2 × Terminated × belantamab mafodotin × Clear all

NCT04676360 2026-03-13

Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma

Phase 2 Terminated

10 enrolled 11 charts

Plasmablastic Lymphoma

NCT05117008 2025-01-28

EMBRACE

Phase 2 Terminated

1 enrolled 5 charts

Multiple Myeloma